Vaccination remains the strongest defense against COVID-19. For more information about where you can schedule a vaccine, be tested for COVID-19 or learn more about the virus, visit https://www.bjc.org/coronavirus.

COVID-19 Information

Dr. Stein Uses Molecular Testing to Inform His Patients’ Cancer Treatment

In 2021, Russell (Russ) Horne and William Sibert were diagnosed with non-small cell lung cancer (NSCLC). They both benefited from molecular profiling of their cancer, known as precision oncology, which identified different and effective treatment approaches.

Matthew Stein, MD, an oncologist and hematologist on staff at Missouri Baptist Medical Center, explained that the genetic makeup of each cancer patient's disease is unique.

"Recent advances in technology enable us to test a patient's cancer for a broad panel of driver gene mutations and other biomarkers with the goal of finding an effective drug or clinical trial. Typically, this testing can be completed in several weeks."

NSCLC is a model for molecular testing, with more than 10 non-chemotherapy FDA-approved treatments for those with advanced or metastatic disease.

Receiving a Cancer Diagnosis

Twenty-nine years into retirement from McDonnell Douglas, Russ said life was good with plenty of time for family and making quilts. However, in late April 2021, he developed a cough with cream-colored
mucus that wouldn't go away. Russ tried taking sinus medication followed by two rounds of antibiotics without relief.

In December 2021, Russ made an appointment with Kiran Sarikonda, MD, a pulmonologist on staff at MoBap, who reviewed a computed tomography (CT) scan to see the condition of his lungs. The test results showed an abnormal consolidation in his lungs.

"Even though I quit smoking in 1982, cancer never entered my mind," Russ said.

Before the end of December, Russ had a biopsy to determine if cancer was present. "I learned I had advanced NSCLC in the left lower lobe of my lung which spread into my lymph nodes."

Like Russ, William Sibert's lung issues began in 2021 when he was diagnosed with COPD (chronic obstructive pulmonary disease) and emphysema. As a retired officer from the St. Louis Police Department and the U.S. Marshals Service, William didn't let his diagnosis slow him down and was enjoying life rehabbing century-old houses.

During follow-up in early 2021 with Bahaa Bedair,MD, a pulmonologist on staff at Missouri Baptist, William learned he had a nodule in his left lung that was identified on a high-resolution CT scan. He had another CT scan in June, where a new left lung mass was identified, in addition to the other nodule. To investigate further, his doctors ordered a positron emission tomography (PET) scan and biopsy, which showed the mass to be NSCLC.

After hearing they had lung cancer, Russ and William both focused on the future. Russ said, "I knew I had a great team of doctors and cancer specialists at MoBap. They listen and support me through every step."

William added he wasn't surprised when he received the diagnosis because the doctors had prepared him for the possibility. "After hearing the news, I focused on a positive mindset by telling myself that I may have cancer, but cancer doesn’t have me."

Profiling Finds Cancer Mutations

After getting his diagnosis, Russ met with Dr. Stein, who recommended molecular profiling to determine the type of mutations in his lung cancer. "By drawing two tubes of blood from Russ' arm and sending it to a commercial lab, we could quickly see if his cancer had certain alterations that would predict a response to targeted therapy."

The test showed Russ' advanced NSCLC contained a BRAF V600E mutation that could be treated with an FDA-approved two-pill combination. "By using this type of precision oncology technique, we were able to find the treatment most likely to help Russ swiftly," Dr. Stein said.

Unlike Russ, William was initially diagnosed with Stage 2 NSCLC, and surgery was planned to remove the mass. Because of the tumor's size and location, William's doctors started him on chemotherapy, hoping to shrink the tumor. However, after two rounds of chemotherapy, it wasn't changing in size.

Dr. Stein performed comprehensive tissue molecular profiling to find out if William's tumor had specific molecular features that could guide further treatment. "The results showed a high PD-L1 score, suggesting his disease could respond to immunotherapy."

Dr. Stein explained that immunotherapy is given as an IV infusion in MoBap's Cancer Infusion Center. "I have treatment every three weeks," William said. He added that he has peace of mind knowing that the
Infusion Center is right by his oncologist's office. "It's a relaxing place with comfortable chairs, privacy curtains and TVs."

Precision Oncology Produces Results

After starting treatment, Russ and William showed improvement. Russ' mucus cleared, his cough went away and he began to feel better. Likewise, William's tumor became smaller and continued to shrink.

Both men also received tailored radiation treatments at Missouri Baptist with the goal of treating any remaining cancer.

William received 30 radiation therapy treatments over six weeks, while Russ had 15 treatments over three weeks.

On June 22, 2022, Russ visited MoBap for a follow-up CT scan to check his lungs, and Dr. Stein told him the test showed no evidence of disease. "I will continue to take the pills at least through the end of the year and will have an echocardiogram and a CT scan with contrast every three months to monitor my lungs."

On June 15, 2022, 11 months after his diagnosis, William had CT scans and received the news that his cancer was barely detectable, with no evidence of recurrence or spread. He will continue to receive immunotherapy infusions and occasional scans.

Getting Back to Living Life

Today, Russ is back at the sewing machine finishing a quilt while planning his next one. "I'm thankful for the professionalism of the entire MoBap team and how everyone worked together to coordinate my treatment. I'm so impressed with my care that I'm switching all my doctors over to those at MoBap."

Sitting on the front steps of his current home rehab project, William is also grateful for the exceptional care he received at MoBap, which helped him keep a positive outlook. Looking to the future, he said, "I'm thankful that people with cancer, like me, have more options for treatment because of all the amazing advances made in cancer over the past few years."

For More Information

To connect with an oncologist at MoBap's Cancer Center, call: 314-996-5151, or visit: MissouriBaptist.org/cancer.

Related Content

Find a Doctor or Make an Appointment

Our new search tool will help you choose a doctor or health care provider that is best for you or your family.

Search Now

Suzanne, a breast cancer survivor, thanks her care team at MoBap

Suzanne Braun credits her care team at Missouri Baptist Medical Center and her own diligence with saving her life. Braun, who went through ovarian cancer in her early 20s, said that health crisis impressed upon her the importance of regular doctor visits and an annual mammogram.

Learn More keyboard_arrow_right

Did You Know?

As the COVID-19 vaccine becomes more widely available, many people wonder whether it's right for them. BJC HealthCare wants you to have the information you need to make the right decision for yourself and your loved ones.

Learn More keyboard_arrow_right

Lung Cancer Screening Results in Early Detection

Michael, a 51-year-old business owner, was a one-pack-a-day cigarette smoker for 30 years who quit in 2017. As someone who enjoyed good health, Michael never worried about his lungs. However, chronic shoulder pain that he attributed to over-exercising and weightlifting began to bother him. On a whim, Michael Googled "causes of shoulder pain" and was surprised when lung cancer came up in the search result.

Learn More keyboard_arrow_right

Getting Back into the Swing After Breast Cancer

As a former marketing executive at Anheuser-Busch and a sales and operations vice president with Staples, Geri saw her diagnosis as just another challenge that needed an execution strategy.

Learn More keyboard_arrow_right
Thumbnail of landing page of the MoBap Cancer Research website

Cancer Research - the leading edge of finding a cure.

Missouri Baptist is part of Heartland Cancer Research, one of 34 community networks that comprise the National Cancer Institute Community Oncology Research Program (NCORP).

Learn More keyboard_arrow_right

Regular Cancer Screenings Save Lives

Cancer screening tests are important because they can identify a malignancy before symptoms appear, when the disease may be easier to treat.

Learn More keyboard_arrow_right

Cancer Registry Report 2019

The Cancer Registry is known for its substantial supportive role in the Missouri Baptist Medical Center’s Cancer Program. The Registry works with physicians, administrators, healthcare providers and planners to provide support for cancer program development, to ensure compliance to regulatory reporting requirements and standards, and to serve as a primary resource for cancer information and statistical information.

Learn More keyboard_arrow_right

Symptoms Lead to Unexpected Diagnoses

When Leslie heard the word, “cancer,” her stomach sank.

Learn More keyboard_arrow_right

MoBap Offers a New FDA-Approved Treatment for People With Advanced Prostate Cancer

 On March 23, 2022, prostate cancer treatment for those with advanced disease took a step forward with the FDA approving the first targeted therapy for the treatment of progressive, PSMA-positive prostate cancer that has spread or metastasized to other parts of the body. Missouri Baptist Medical Center is one of three sites in Missouri that is currently offering this treatment.

Learn More keyboard_arrow_right

Katie Celebrates Remission After Treatment for Endometrial Cancer

Katie was at a crossroads about where to receive additional cancer treatment to help prevent her cancer from returning. “I chose Missouri Baptist because they have a great reputation for cutting-edge cancer therapies and care.”

Learn More keyboard_arrow_right

Dr. Stein Uses Molecular Testing to Inform His Patients' Cancer Treatment

In 2021, Russell (Russ) Horne and William Sibert were diagnosed with non-small cell lung cancer (NSCLC). They both benefited from molecular profiling of their cancer, known as precision oncology, which identified different and effective treatment approaches.

Learn More keyboard_arrow_right

Should You be Screened for Lung Cancer?

Lung cancer is one of the most common cancers in the world. Often the disease does not show symptoms until it has progressed to advanced stages, when it is difficult to treat and chances of survival decrease. A low-radiation-dose CT scan can detect lung cancer at its earliest stages, making treatment both easier and more effective.

Learn More keyboard_arrow_right

Take 5 for Lung Cancer

Lung cancer is one of the most common cancers in the world; yet recent research shows most people know very little about the disease. Did you know that more people in the United States die from lung cancer than any other type of cancer?

Learn More keyboard_arrow_right

An Inside Look

Since launching in November 2014, the Missouri Baptist Medical Center Computed Tomography (CT) Lung Cancer Screening has screened 2,594 people for early-stage lung cancer. Forty-six of them had cancer. 

David Patton is one of those. Read how the nurse navigator assisted him through the program.

Learn More keyboard_arrow_right

New Patients and Family Information

Learn More keyboard_arrow_right

Cancer Registry Report 2018

The Cancer Registry is known for its substantial supportive role in the Missouri Baptist Medical Center’s Cancer Program. The Registry works with physicians, administrators, healthcare providers and planners to provide support for cancer program development, to ensure compliance to regulatory reporting requirements and standards, and to serve as a primary resource for cancer information and statistical information.

Learn More keyboard_arrow_right

Cancer Registry Report 2017

The Cancer Registry is known for its substantial supportive role in the Missouri Baptist Medical Center’s Cancer Program. The Registry works with physicians, administrators, healthcare providers and planners to provide support for cancer program development, to ensure compliance to regulatory reporting requirements and standards, and to serve as a primary resource for cancer information and statistical information.

Learn More keyboard_arrow_right

Palliative Care: Helping Patients Live Their Best Lives

Lynn’s husband Steve was diabetic and diagnosed with end stage renal disease 11 years ago. Without warning, Steve’s condition turned critical three years ago. Desperate for guidance and strength, Lynn was connected to April and the Palliative Care team at Missouri Baptist Medical Center.

Learn More keyboard_arrow_right

Meet the MoBap Cancer Care Team

You’ll be glad to know that the physicians at Missouri Baptist Cancer Center are all leading cancer specialists. Our physician team includes board-certified specialists that are involved in investigational research and use the latest diagnostic and treatment options for our cancer patients.

Learn More keyboard_arrow_right

Rapid Referral

We understand that every second counts in the fight against cancer. With every cancer diagnosis comes a host of possible emotional responses:  uncertainty, anger, and most of all – fear.  That is why we see patients within 48 hours after referral to our Cancer Center.

Learn More keyboard_arrow_right

Advanced Treatment When You Need It Most

Missouri Baptist Cancer Center is committed to offering patients the most advanced treatment and surgical options available. As early adopters of new technology, Missouri Baptist Cancer Center offers both  RapidArc™ Therapy and the da Vinci® Surgical System.

Learn More keyboard_arrow_right

Bring down the swelling (and your stress).

Lymphedema is a type of chronic swelling that can occur if there is damage to the lymphatic system or if the lymphatic system becomes overloaded by excess fluid due to infection or other medical issues, such as surgery, radiation or trauma to the lymph vessels. 

As the first and only National Lymphedema Network  Affiliate Treatment Center in the St. Louis area, find out how the Center for Outpatient Therapy and Wellness can help.

Learn More keyboard_arrow_right

Rural Outreach Brings Clinical Trials to Patients

Patients like Mary Elise, a retired teacher in Ste. Genevieve, can take part in advanced clinical research thanks to the Missouri Baptist Cancer Center involvement with the Heartland Cancer Research NCORP. As part of the TAILORx trial, Mary Elise help researchers studying the effects of chemotherapy on early-state cancer.

Learn More keyboard_arrow_right
Prostate cancer  is the most common form of cancer in men. According to the  American Cancer Society, one in nine  men will be diagnosed with prostate  cancer during his lifetime. It is a statistic that Craig Siegel never expected he'd be among.

Living with Prostate Cancer

Prostate cancer is the most common form of cancer in men. According to the American Cancer Society, one in nine men will be diagnosed with prostate cancer during his lifetime.

Learn More keyboard_arrow_right